| Dr Sharon Oehler, MD | |
|
440 East Marshall St, 3rd Flr North, Suite 300, West Chester, PA 19380 | |
| (610) 436-8611 | |
| (610) 436-1193 |
| Full Name | Dr Sharon Oehler |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 440 East Marshall St, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528082815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD-028718-E (Pennsylvania) | Primary |
| Entity Name | Childrens Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598869059 PECOS PAC ID: 1355253527 Enrollment ID: O20040216001108 |
News Archive
Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer - a Chilean-based research laboratory - to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.
An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon Oehler, MD 440 East Marshall St, 3rd Flr North, Suite 300, West Chester, PA 19380 Ph: (610) 436-8611 | Dr Sharon Oehler, MD 440 East Marshall St, 3rd Flr North, Suite 300, West Chester, PA 19380 Ph: (610) 436-8611 |
News Archive
Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer - a Chilean-based research laboratory - to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.
An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
› Verified 4 days ago
Annamarie Koller, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5376 Fax: 610-431-5527 | |
Dr. Shanti Krishnan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 440 East Marshall Street, Third Floor North. Suite 300, West Chester, PA 19380 Phone: 610-436-8611 Fax: 610-436-1193 | |
Michelle Quirk, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5376 Fax: 610-431-5527 | |
Amy Baumgartner Akins, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 440 E Marshall St, Third Floor North, Suite 300, West Chester, PA 19380 Phone: 610-436-8611 Fax: 610-436-1193 | |
Dr. Jeffrey Fendrick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 440 East Marshall St, 3rd Flr North, Suite 300, West Chester, PA 19380 Phone: 610-436-8611 Fax: 610-436-1193 | |
Dr. Jennifer Jane Hesler, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 E Marshall St, Chop Care Network At Chester County Hospital, West Chester, PA 19380 Phone: 610-431-5376 Fax: 610-431-5527 | |
Christina Logan, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 770 Miles Rd Ste 1, West Chester, PA 19380 Phone: 610-436-8611 |